ID   KC1G3_HUMAN             Reviewed;         447 AA.
AC   Q9Y6M4; A8K040; B4DSH2; B7Z9Q4; E7EVD0; Q86WZ7; Q9Y6M3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   12-OCT-2022, entry version 196.
DE   RecName: Full=Casein kinase I isoform gamma-3;
DE            Short=CKI-gamma 3;
DE            EC=2.7.11.1;
GN   Name=CSNK1G3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=9925945; DOI=10.1159/000015143;
RA   Kusuda J., Hirai M., Toyoda A., Tanuma R., Hashimoto K.;
RT   "Cloning and chromosome mapping of the human casein kinase I gamma3 gene
RT   (CSNK1G3).";
RL   Cytogenet. Cell Genet. 83:101-103(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5 AND 6).
RC   TISSUE=Astrocyte, Brain, and Embryonic brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366 (ISOFORM 3),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367 (ISOFORM 4),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-291 (ISOFORM 5),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254 (ISOFORM 6), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13] {ECO:0007744|PDB:2CHL}
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 35-362 IN COMPLEX WITH THE
RP   INHIBITOR TRIAZOLODIAMINE 1, AND ACTIVITY REGULATION.
RA   Bunkoczi G., Salah E., Rellos P., Das S., Fedorov O., Savitsky P.,
RA   Gileadi O., Sundstrom M., Edwards A., Arrowsmith C., Ugochukwu E.,
RA   Weigelt J., Von Delft F., Knapp S.;
RT   "Structure of casein kinase 1 gamma 3.";
RL   Submitted (MAR-2006) to the PDB data bank.
RN   [14] {ECO:0007744|PDB:2IZR, ECO:0007744|PDB:2IZS, ECO:0007744|PDB:2IZT, ECO:0007744|PDB:2IZU}
RP   X-RAY CRYSTALLOGRAPHY (1.30 ANGSTROMS) OF 35-362 IN COMPLEX WITH
RP   INHIBITORS, AND ACTIVITY REGULATION.
RA   Bunkoczi G., Salah E., Rellos P., Das S., Fedorov O., Savitsky P.,
RA   Debreczeni J.E., Gileadi O., Sundstrom M., Edwards A., Arrowsmith C.,
RA   Weigelt J., Von Delft F., Knapp S.;
RT   "Inhibitor binding by casein kinases.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Serine/threonine-protein kinase. Casein kinases are
CC       operationally defined by their preferential utilization of acidic
CC       proteins such as caseins as substrates. It can phosphorylate a large
CC       number of proteins. Participates in Wnt signaling. Regulates fast
CC       synaptic transmission mediated by glutamate (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Inhibited by triazolodiamine 1 (5-amino-3-([4-
CC       (aminosulfonyl)phenyl]amino)-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-
CC       1-carbothioamide), (S)-propane-1,2-diol, 2-({6-[(3-chlorophenyl)amino]-
CC       9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol, N2-[(1R,2S)-2-
CC       aminocyclohexyl]-N6-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine and
CC       [4-amino-2-(3-chloroanilino)-1,3-thiazol-5-yl](4-
CC       fluorophenyl)methanone. {ECO:0000269|Ref.13, ECO:0000269|Ref.14}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9Y6M4-3; Q6PGQ1: DRICH1; NbExp=3; IntAct=EBI-11045281, EBI-10253641;
CC       Q9Y6M4-3; P60014: KRTAP10-10; NbExp=3; IntAct=EBI-11045281, EBI-11955579;
CC       Q9Y6M4-3; Q99750: MDFI; NbExp=3; IntAct=EBI-11045281, EBI-724076;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=3;
CC         IsoId=Q9Y6M4-1; Sequence=Displayed;
CC       Name=2; Synonyms=3L, CSNK1G3L;
CC         IsoId=Q9Y6M4-2; Sequence=VSP_004749;
CC       Name=3;
CC         IsoId=Q9Y6M4-3; Sequence=VSP_010256, VSP_004749;
CC       Name=4;
CC         IsoId=Q9Y6M4-4; Sequence=VSP_047055, VSP_010256, VSP_004749;
CC       Name=5;
CC         IsoId=Q9Y6M4-5; Sequence=VSP_047054, VSP_010256, VSP_004749;
CC       Name=6;
CC         IsoId=Q9Y6M4-6; Sequence=VSP_047053, VSP_047055, VSP_010256,
CC                                  VSP_004749;
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF049089; AAD26525.1; -; mRNA.
DR   EMBL; AF049090; AAD26526.1; -; mRNA.
DR   EMBL; AK289405; BAF82094.1; -; mRNA.
DR   EMBL; AK299739; BAG61634.1; -; mRNA.
DR   EMBL; AK316019; BAH14390.1; -; mRNA.
DR   EMBL; AC008541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471086; EAW48872.1; -; Genomic_DNA.
DR   EMBL; BC047567; AAH47567.1; -; mRNA.
DR   CCDS; CCDS34218.1; -. [Q9Y6M4-3]
DR   CCDS; CCDS4135.1; -. [Q9Y6M4-1]
DR   CCDS; CCDS43355.1; -. [Q9Y6M4-2]
DR   CCDS; CCDS59491.1; -. [Q9Y6M4-4]
DR   CCDS; CCDS59492.1; -. [Q9Y6M4-5]
DR   CCDS; CCDS59493.1; -. [Q9Y6M4-6]
DR   RefSeq; NP_001026982.1; NM_001031812.3. [Q9Y6M4-3]
DR   RefSeq; NP_001038188.1; NM_001044723.2. [Q9Y6M4-2]
DR   RefSeq; NP_001257501.1; NM_001270572.1. [Q9Y6M4-4]
DR   RefSeq; NP_001257502.1; NM_001270573.1. [Q9Y6M4-5]
DR   RefSeq; NP_001257503.1; NM_001270574.1. [Q9Y6M4-6]
DR   RefSeq; NP_004375.2; NM_004384.4. [Q9Y6M4-1]
DR   RefSeq; XP_005271949.1; XM_005271892.2. [Q9Y6M4-2]
DR   RefSeq; XP_005271951.1; XM_005271894.2. [Q9Y6M4-1]
DR   RefSeq; XP_005271952.1; XM_005271895.2. [Q9Y6M4-4]
DR   RefSeq; XP_016864558.1; XM_017009069.1. [Q9Y6M4-4]
DR   PDB; 2CHL; X-ray; 1.95 A; A=35-362.
DR   PDB; 2IZR; X-ray; 1.30 A; A=35-362.
DR   PDB; 2IZS; X-ray; 1.95 A; A=35-362.
DR   PDB; 2IZT; X-ray; 2.00 A; A=35-362.
DR   PDB; 2IZU; X-ray; 1.85 A; A=35-362.
DR   PDB; 4G16; X-ray; 2.30 A; A=34-362.
DR   PDB; 4G17; X-ray; 2.10 A; A=34-362.
DR   PDB; 4HGL; X-ray; 2.40 A; A=34-362.
DR   PDB; 4HGS; X-ray; 2.40 A; A=34-362.
DR   PDB; 6GRO; X-ray; 1.45 A; A=33-362.
DR   PDBsum; 2CHL; -.
DR   PDBsum; 2IZR; -.
DR   PDBsum; 2IZS; -.
DR   PDBsum; 2IZT; -.
DR   PDBsum; 2IZU; -.
DR   PDBsum; 4G16; -.
DR   PDBsum; 4G17; -.
DR   PDBsum; 4HGL; -.
DR   PDBsum; 4HGS; -.
DR   PDBsum; 6GRO; -.
DR   AlphaFoldDB; Q9Y6M4; -.
DR   SMR; Q9Y6M4; -.
DR   BioGRID; 107840; 132.
DR   IntAct; Q9Y6M4; 43.
DR   MINT; Q9Y6M4; -.
DR   STRING; 9606.ENSP00000353904; -.
DR   BindingDB; Q9Y6M4; -.
DR   ChEMBL; CHEMBL5084; -.
DR   DrugBank; DB07489; 4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium.
DR   DrugBank; DB07664; K-00546.
DR   DrugBank; DB04751; Purvalanol A.
DR   DrugBank; DB07488; {4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone.
DR   DrugCentral; Q9Y6M4; -.
DR   iPTMnet; Q9Y6M4; -.
DR   PhosphoSitePlus; Q9Y6M4; -.
DR   SwissPalm; Q9Y6M4; -.
DR   BioMuta; CSNK1G3; -.
DR   DMDM; 47117932; -.
DR   EPD; Q9Y6M4; -.
DR   jPOST; Q9Y6M4; -.
DR   MassIVE; Q9Y6M4; -.
DR   MaxQB; Q9Y6M4; -.
DR   PaxDb; Q9Y6M4; -.
DR   PeptideAtlas; Q9Y6M4; -.
DR   PRIDE; Q9Y6M4; -.
DR   ProteomicsDB; 1831; -.
DR   ProteomicsDB; 18613; -.
DR   ProteomicsDB; 5025; -.
DR   ProteomicsDB; 86730; -. [Q9Y6M4-1]
DR   ProteomicsDB; 86731; -. [Q9Y6M4-2]
DR   ProteomicsDB; 86732; -. [Q9Y6M4-3]
DR   Antibodypedia; 25674; 170 antibodies from 27 providers.
DR   DNASU; 1456; -.
DR   Ensembl; ENST00000345990.9; ENSP00000334735.5; ENSG00000151292.18. [Q9Y6M4-2]
DR   Ensembl; ENST00000360683.6; ENSP00000353904.2; ENSG00000151292.18. [Q9Y6M4-2]
DR   Ensembl; ENST00000361991.6; ENSP00000354942.2; ENSG00000151292.18. [Q9Y6M4-1]
DR   Ensembl; ENST00000510842.6; ENSP00000423838.2; ENSG00000151292.18. [Q9Y6M4-4]
DR   Ensembl; ENST00000511130.6; ENSP00000421385.2; ENSG00000151292.18. [Q9Y6M4-6]
DR   Ensembl; ENST00000512718.7; ENSP00000421998.3; ENSG00000151292.18. [Q9Y6M4-5]
DR   Ensembl; ENST00000521364.5; ENSP00000429412.1; ENSG00000151292.18. [Q9Y6M4-3]
DR   GeneID; 1456; -.
DR   KEGG; hsa:1456; -.
DR   UCSC; uc003ktn.5; human. [Q9Y6M4-1]
DR   CTD; 1456; -.
DR   DisGeNET; 1456; -.
DR   GeneCards; CSNK1G3; -.
DR   HGNC; HGNC:2456; CSNK1G3.
DR   HPA; ENSG00000151292; Low tissue specificity.
DR   MIM; 604253; gene.
DR   neXtProt; NX_Q9Y6M4; -.
DR   OpenTargets; ENSG00000151292; -.
DR   PharmGKB; PA26956; -.
DR   VEuPathDB; HostDB:ENSG00000151292; -.
DR   eggNOG; KOG1165; Eukaryota.
DR   GeneTree; ENSGT00940000160646; -.
DR   HOGENOM; CLU_019279_2_0_1; -.
DR   InParanoid; Q9Y6M4; -.
DR   OMA; TGFQKFM; -.
DR   OrthoDB; 889559at2759; -.
DR   PhylomeDB; Q9Y6M4; -.
DR   TreeFam; TF313349; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q9Y6M4; -.
DR   SignaLink; Q9Y6M4; -.
DR   BioGRID-ORCS; 1456; 10 hits in 1117 CRISPR screens.
DR   ChiTaRS; CSNK1G3; human.
DR   EvolutionaryTrace; Q9Y6M4; -.
DR   GenomeRNAi; 1456; -.
DR   Pharos; Q9Y6M4; Tchem.
DR   PRO; PR:Q9Y6M4; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9Y6M4; protein.
DR   Bgee; ENSG00000151292; Expressed in calcaneal tendon and 199 other tissues.
DR   ExpressionAtlas; Q9Y6M4; baseline and differential.
DR   Genevisible; Q9Y6M4; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0036211; P:protein modification process; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR022247; Casein_kinase-1_gamma_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12605; CK1gamma_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   CHAIN           1..447
FT                   /note="Casein kinase I isoform gamma-3"
FT                   /id="PRO_0000192846"
FT   DOMAIN          43..313
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          341..374
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          391..416
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..20
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        346..361
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        392..416
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        162
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         49..57
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         72
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   VAR_SEQ         1..113
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047053"
FT   VAR_SEQ         1..75
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047054"
FT   VAR_SEQ         282
FT                   /note="E -> EE (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047055"
FT   VAR_SEQ         363..394
FT                   /note="Missing (in isoform 3, isoform 4, isoform 5 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010256"
FT   VAR_SEQ         430
FT                   /note="K -> NCQKVLNMW (in isoform 2, isoform 3, isoform 4,
FT                   isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9925945"
FT                   /id="VSP_004749"
FT   CONFLICT        91
FT                   /note="K -> E (in Ref. 5; AAH47567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        174
FT                   /note="G -> R (in Ref. 1; AAD26525/AAD26526)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        241
FT                   /note="Y -> C (in Ref. 2; BAH14390)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        302
FT                   /note="D -> E (in Ref. 1; AAD26525/AAD26526)"
FT                   /evidence="ECO:0000305"
FT   TURN            40..42
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          43..48
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          50..52
FT                   /evidence="ECO:0007829|PDB:2IZS"
FT   STRAND          56..62
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   TURN            63..66
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          67..75
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           83..93
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          102..108
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          111..117
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           123..129
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           136..155
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           165..167
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          168..170
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           173..175
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   TURN            176..179
FT                   /evidence="ECO:0007829|PDB:6GRO"
FT   STRAND          180..183
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          190..193
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   TURN            195..197
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   STRAND          198..200
FT                   /evidence="ECO:0007829|PDB:2IZU"
FT   TURN            213..215
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           218..221
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           228..244
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   TURN            248..251
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           257..270
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           273..276
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   TURN            277..279
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           281..292
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   HELIX           301..314
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   TURN            324..327
FT                   /evidence="ECO:0007829|PDB:2IZR"
FT   MOD_RES         Q9Y6M4-3:366
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         Q9Y6M4-4:367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         Q9Y6M4-5:291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         Q9Y6M4-6:254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
SQ   SEQUENCE   447 AA;  51389 MW;  6FAEDD605579ED3A CRC64;
     MENKKKDKDK SDDRMARPSG RSGHNTRGTG SSSSGVLMVG PNFRVGKKIG CGNFGELRLG
     KNLYTNEYVA IKLEPMKSRA PQLHLEYRFY KQLGSGDGIP QVYYFGPCGK YNAMVLELLG
     PSLEDLFDLC DRTFSLKTVL MIAIQLISRM EYVHSKNLIY RDVKPENFLI GRPGNKTQQV
     IHIIDFGLAK EYIDPETKKH IPYREHKSLT GTARYMSINT HLGKEQSRRD DLEALGHMFM
     YFLRGSLPWQ GLKADTLKER YQKIGDTKRA TPIEVLCENF PEMATYLRYV RRLDFFEKPD
     YDYLRKLFTD LFDRKGYMFD YEYDWIGKQL PTPVGAVQQD PALSSNREAH QHRDKMQQSK
     NQSADHRAAW DSQQANPHHL RAHLAADRHG GSVQVVSSTN GELNTDDPTA GRSNAPITAP
     TEVEVMDETK CCCFFKRRKR KTIQRHK
//
